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Abstract
Background: Many studies report a positive association between smoking and mental illness. 
However, the literature remains mixed regarding the direction of this association. We therefore 
conducted a systematic review evaluating the association of smoking and depression and/or anxi-
ety in longitudinal studies.
Methods: Studies were identified by searching PubMed, Scopus, and Web of Science and were 
included if they: (1) used human participants, (2) were longitudinal, (3) reported primary data, (4) 
had smoking as an exposure and depression and/or anxiety as an outcome, or (5) had depression 
and/or anxiety as the exposure and smoking as an outcome.
Results: Outcomes from 148 studies were categorized into: smoking onset, smoking status, smok-
ing heaviness, tobacco dependence, and smoking trajectory. The results for each category varied 
substantially, with evidence for positive associations in both directions (smoking to later mental 
health and mental health to later smoking) as well as null findings. Overall, nearly half the stud-
ies reported that baseline depression/anxiety was associated with some type of later smoking 
behavior, while over a third found evidence that a smoking exposure was associated with later 
depression/anxiety. However, there were few studies directly supporting a bidirectional model of 
smoking and anxiety, and very few studies reporting null results.
Conclusions: The literature on the prospective association between smoking and depression and 
anxiety is inconsistent in terms of the direction of association most strongly supported. This sug-
gests the need for future studies that employ different methodologies, such as Mendelian rand-
omization (MR), which will allow us to draw stronger causal inferences.
Implications: We systematically reviewed longitudinal studies on the association of differ-
ent aspects of smoking behavior with depression and anxiety. The results varied consider-
ably, with evidence for smoking both associated with subsequent depression and anxiety, and 
vice versa. Few studies supported a bidirectional relationship, or reported null results, and 
no clear patterns by gender, ethnicity, clinical status, length to follow-up, or diagnostic test. 
Suggesting that despite advantages of longitudinal studies, they cannot alone provide strong 
evidence of causality. Therefore, future studies investigating this association should employ 
different methods allowing for stronger causal inferences to be made, such as MR.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits 
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 Nicotine & Tobacco Research Advance Access published May 31, 2016
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Introduction
The high co-occurrence of smoking and mental illness is a major 
public health concern, and smoking accounts for much of the 
reduction in life expectancy associated with mental illness.1 Many 
studies report a positive association between smoking and men-
tal illness, with smoking rates increasing with the severity of the 
disease.2,3 Individuals with mental illness also tend to start smok-
ing at an earlier age, smoke more heavily, and are more addicted 
to cigarettes than the general population. For example, a recent 
survey suggests that 42% of all cigarettes consumed in England 
are consumed by those with mental illness, although this includes 
substance use disorders.4 Additionally, while cigarette consump-
tion in the general population has shown a sustained decrease over 
the past 20 years, consumption among smokers with mental illness 
has remained relatively unchanged.1 There is therefore a pressing 
need to understand the mechanisms underlying the high rate of 
smoking in people with mental illness. Here, we focus specifically 
on the relationship between cigarette smoking and depression and 
anxiety.
Currently, there are several hypotheses that have been proposed 
to explain the high rates of smoking in people with depression and 
anxiety. The self-medication hypothesis postulates that individu-
als turn to smoking to alleviate their symptoms5–7 and therefore 
suggests that symptoms of depression and anxiety may lead to 
smoking. An alternative hypothesis is that smoking may lead to 
depression or anxiety, through effects on an individual’s neuro-
circuitry that increases susceptibility to environmental stressors. 
Animal models indicate that prolonged nicotine exposure dys-
regulates the hypothalamic–pituitary–adrenal system, resulting 
in hypersecretion of cortisol and alterations in the activity of the 
associated monoamine neurotransmitter system, whose function is 
to regulate reactions to stressors,8 an effect that appears to normal-
ize after nicotine withdrawal.9 The association between smoking 
and depression/anxiety may also be bidirectional, with occasional 
smoking initially used to alleviate symptoms, but in fact wors-
ening them over time.10 Finally, there may in fact be no causal 
relationship between smoking and depression/anxiety. Instead, the 
association may be a product of shared risk factors (eg, common 
genetic influences)10,11 or confounding. Smokers may also report 
that cigarettes alleviate their symptoms due to the misattribu-
tion of withdrawal relief. Given the short half-life of nicotine that 
results in withdrawal symptoms (including mood symptoms) after 
a short period of abstinence, smokers may misattribute the relief 
of short-term withdrawal as reflecting a genuine anxiolytic effect 
of smoking.7 That is, withdrawal symptoms of increased anxiety 
and negative affect may be misattributed as reflecting genuine 
mood symptoms, which would lead to the impression that smok-
ing improves mood.
We are therefore presented with multiple different hypotheses 
regarding whether there is a causal relationship between smoking 
and depression/anxiety and if so, what the direction of causality 
underlying this relationship is. While experimental studies are gener-
ally not possible, for both practical and ethical reasons, longitudinal 
studies may help inform our understanding of the causal relationship 
between smoking and depression/anxiety by clarifying the temporal 
association. Our study aimed to systematically review the literature 
comprising longitudinal studies of the associations between smoking 
and depression/anxiety and conduct meta-analyses where possible. 
To the best of our knowledge, this is the first systematic review of 
this literature.
Methods
Identification of Studies
We searched PubMed, Scopus, and Web of Science up until August 
1, 2015 using the following search terms: depressi*, anxi*, smok*, 
tobacco, nicotine, cigarette, caus*, cohort, prospective, longitudinal. 
The term animal* was specified for exclusion. Two authors (MF and 
AT) reviewed the electronic abstracts, selecting the full-text articles 
to be included.
Selection Criteria
Studies were included in the review if they met the following crite-
ria: (1) human participants, (2) smoking as the exposure variable 
and depression and/or anxiety as the outcome variable, or vice versa 
(depression and/or anxiety as the exposure variable and smoking 
as the outcome variable), (3) longitudinal study design, and (4) 
reported primary data not previously reported elsewhere. Studies 
involving cessation, withdrawal, suicide, or trauma, which recruited 
participants who were pregnant or diagnosed with a psychiatric 
illness other than depression or anxiety, or included participants 
with depression and anxiety comorbid with another psychiatric ill-
ness were excluded. Studies not utilizing a validated diagnostic test 
for depression or anxiety were excluded. Studies investigating the 
association of parental smoking on offspring outcomes were also 
excluded, as were all experimental studies (eg, randomized con-
trolled trials of smoking cessation interventions). RCTs as well as 
secondary analyses of randomized controlled trials were excluded.
Data Extraction
The following information was extracted from each of the included 
studies, by one author (MF): type of depression/anxiety (major 
depression, generalized anxiety disorder, mixed major depression, 
and generalized anxiety disorder), method of measuring depression/
anxiety (self-report via diagnostic test, clinical interview, or physi-
cian diagnosis) and scale used (continuous or categorical), smoking 
behavior (age of smoking onset, smoking status, heaviness of smok-
ing, tobacco dependence, smoking trajectory), sample size, mean 
age of participants and sex distribution of participants, population 
sampled (eg, general or clinical), and length of follow up. A 100% 
data check was performed by the same author (MF) and a 10% 
data check was independently performed by another author (MG) 
to identify data extraction errors. Any errors identified were resolved 
by mutual consent.
Rationale for not Conducting Meta-analysis
A meta-analysis was not conducted as, even within the general 
population samples available, there was substantial heterogeneity 
(age, location, covariates used, time to follow up, and number of 
times and frequency of outcomes sampled). Additionally, the stud-
ies included were not limited to only those examining an a priori 
hypothesis of mental health and smoking; studies were included if 
they contained the desired outcome and exposure variables within 
their data set.
Results
Characteristics of Included Studies
Of the 6232 abstracts reviewed, 5514 were excluded on the basis of 
title and 404 after reviewing the abstract. In total, 314 articles were 
retrieved and assessed for eligibility, and 148 met inclusion criteria 
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(Figure 1). Details of included studies are provided in Supplementary 
Table S1 and details of excluded full-text studies in Supplementary 
Table S2.
Studies ranged in sample size from 59 to 90 627 participants 
and in length of follow up from 2 months to 36 years. Of the 148 
included studies, 99 (67%) recruited male and female participants, 
16 (11%) recruited only females and 7 (5%) recruited only males, 
while 26 (18%) did not report the sex of the participants. In addi-
tion, 101 studies (70%) sampled participants from the general pop-
ulation, 15 (10%) from clinical populations, and 16 (10%) from 
particular ethnic groups, while 16 (10%) had other selection criteria 
(see Supplementary Table S2).
Unless otherwise stated, the associations described refer to a posi-
tive relationship between smoking and depression/anxiety (ie, smok-
ing is associated with increased depression/anxiety, or increased 
depression/anxiety is associated with increased smoking).
Smoking Categories
Studies were categorized based on the basis of the smoking 
behavior(s) they assessed: smoking onset, smoking status, smoking 
heaviness, tobacco dependence, and smoking trajectory. Studies with 
measures of daily or weekly cigarette use were included in the smok-
ing heaviness category. Studies that were able to establish the onset of 
smoking from an initially nonsmoking population were included in 
the smoking onset category. Studies that measured tobacco depend-
ence, for example, through the DSM-IV12 or the Fagerström Test for 
Nicotine Dependence,13 were included in the tobacco dependence 
category. Studies that tracked the different paths of cigarette smok-
ing uptake and use in a cohort were included in the smoking trajec-
tory category, and studies that defined smokers in purely categorical 
terms (eg, current, former, and never) were included in the smoking 
status category. Table  1 summarizes the directions of associations 
investigated within the studies in each smoking category.
Smoking Onset
A total of 14 studies investigated the association of baseline depres-
sion with subsequent smoking onset, of which 10 (71%) found evi-
dence to support this association,14–23 while four (29%) found no 
evidence of an association.24–27 Five studies investigated the associa-
tion of baseline anxiety on smoking onset, of which four (80%) found 
evidence to support an association with increased risk of smoking 
onset24,28–30 and one (20%) found no evidence of an association.21 Six 
studies investigated the association of comorbid depression and anx-
iety with later smoking onset, of which two (33%) found evidence 
to support this association,31,32 while one (17%) reported comorbid 
depression and anxiety was associated with reduced risk of smoking 
onset33 and three (50%) found no evidence of an association.34–36 
One study investigated the association of smoking onset with later 
depression, finding evidence for this association.15 One study investi-
gated the association of smoking onset with later anxiety, finding no 
evidence for this association.21 Additionally one study investigated 
the association of smoking onset with later comorbid depression and 
Figure 1. Identification of independent studies for inclusion in systematic review.
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anxiety, finding no evidence for this association.31 These findings are 
summarized in Figure 2.
Smoking Status
A total of 37 studies investigated the association of baseline depression 
with subsequent smoking status, of which 33 (89%) found evidence to 
support this association,21,37–66 while four (11%) found no evidence of 
an association.67–70 One study investigated the association of anxiety 
with later smoking status, finding evidence of an association.28 One 
study investigated the association of comorbid depression and anxi-
ety with later smoking status, finding no evidence of an association.71
A total of 51 studies investigated the association of smoking 
status with later depression, of which 37 (73%) found evidence 
to support this association,21,25,47,57,65,70,72–102 while 14 (27%) found 
no evidence of this association.28,38,48,64,69,103–111 Four studies investi-
gated the association of smoking status with later anxiety, of which 
two (50%) found evidence to support this association,28,112 while 
two (50%) found no evidence of an association.21,103 Seven studies 
investigated the association of smoking status with later comorbid 
depression and anxiety, of which five (71%) found evidence to sup-
port this association,35,113–116 while two (29%) found no evidence of 
an association.117,118 These findings are summarized in Figure 2.
Figure 2. Main outcomes by smoking category.
Table 1. Directions of Associations Investigated by Smoking Category
Category
Depression Anxiety Comorbid depression and anxiety
MH into 
smoking
Smoking 
into MH Bidirectional
MH into 
smoking
Smoking 
into MH Bidirectional
MH into 
smoking
Smoking 
into MH Bidirectional
Smoking onset 13 0 1 4 0 2 5 0 1
Smoking status 29 40 8 0 4 1 1 7 0
Smoking heaviness 9 7 2 1 1 0 0 1 0
Tobacco dependence 12 2 1 6 0 0 5 1 0
Smoking trajectory 7 2 0 1 0 0 1 1 0
Any smoking category 70 51 12 12 5 3 12 10 1
The number of studies investigating each direction(s) of association for each smoking category is shown. Studies investigating multiple directions are repeated 
within smoking category. Please note these only include directions investigated and differ from the overall findings within smoking groups detailed in Figure 2. 
MH = mental health outcome.
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Smoking Heaviness
A total of 11 studies investigated the association of baseline depres-
sion with subsequent heaviness of smoking, of which eight (73%) 
found evidence that depression was associated with heavier rates of 
smoking,22,119–125 while two (18%) found that depression was associ-
ated with reduced heaviness of smoking26,126 and one (09%) found no 
evidence of an association.127 One study investigated the association 
of baseline anxiety with subsequent smoking heaviness and found no 
evidence of an association.124 Eight studies investigated the associa-
tion of heaviness of smoking with later depression, of which seven 
(88%) found evidence to support this association,11,82,95,102,125,127,128 
while one (13%) found no evidence of an association.129 One study 
investigated the association of heaviness of smoking with later anxi-
ety and found evidence to support this association.130 One study 
investigated the association of heaviness of smoking with later 
comorbid depression and anxiety, finding no evidence of an associa-
tion.117 These findings are summarized in Figure 2.
Tobacco Dependence
A total of 13 studies investigated the association of baseline depres-
sion with subsequent tobacco dependence, of which 12 (92%) found 
evidence to support this association29,120,131–140 while one (8%) found 
no evidence of an association.141 Six studies investigated the associa-
tion of baseline anxiety with later tobacco dependence, of which two 
(33%) found evidence to support this association,140,142 while four 
(67%) found no evidence of an association.132,137,139,143 Five studies 
investigated baseline comorbid depression and anxiety with subse-
quent tobacco dependence, of which three (60%) found evidence to 
support this association, 144–146 while two (40%) found no evidence 
of an association.35,147 Three studies investigated the association 
of tobacco dependence with later depression, of which two (67%) 
found evidence to support this association,6,132 while one (33%) 
found no evidence of an association.148 Two studies investigated the 
association of tobacco dependence with later comorbid depression 
and anxiety, of which one (50%) found evidence to support this 
association,149 while one (50%) found no evidence of an associa-
tion.147 These findings are summarized in Figure 2.
Smoking Trajectory
A total of seven studies investigated the association of baseline depres-
sion with smoking trajectory, of which one (14%) reported that 
depressive symptoms were associated with accelerated cigarette use,150 
three (43%) reported that depressive symptoms were associated with 
early smoking onset,17,43,151 one reported that depressive symptoms 
were associated with late onset smoking152 and two (29%) found 
no evidence of an association.153,154. One study reported evidence of 
an association of baseline anxiety with early and late onset smok-
ing patterns.155 Another study reported evidence of an association of 
baseline comorbid depression and anxiety with late onset smoking as 
opposed to experimental smoking.156 One study reported that indi-
viduals in (smoking) starter and maintaining groups were more likely 
to be depressed at follow up compared with nonsmoking groups.157 
Finally, one study reported evidence that early onset smokers devel-
oped depression and anxiety approximately five years earlier than late 
onset smokers.158 These findings are summarized in Figure 2.
Bidirectional Studies
Sixteen (11%) of the 148 included studies investigated the associa-
tion between smoking behavior and mental health bidirectionally (ie, 
both the association between baseline mental health and later smok-
ing behavior and baseline smoking behavior and later mental health). 
Of these, seven (44%) reported evidence in support of a bidirectional 
relationship between depression and smoking15,21,47,57,65,125,132 and one 
(9%) reported evidence in support of a bidirectional relationship 
between anxiety and smoking.28
Sex Differences
A total of eight studies (7% of all studies including both males 
and females) reported that the relationship between smoking and 
depression/anxiety differed between males and females. Two studies 
reported that depression was associated with subsequent smoking 
behavior only in males,23,64 while one study reported depression was 
associated with subsequent smoking only in females66 and one study 
reported that anxiety was associated with later smoking behavior 
only in females.140 Additionally, one study reported evidence that 
smoking status in men was associated with later depression,101 and 
two studies reported evidence that smoking status had a stronger 
association with later depression in females than males.97,157 Finally, 
one study reported a bidirectional relationship between smoking and 
depression that was only observed in females.57
Clinical Studies
Five studies investigated participants with cardiovascular problems. 
One study reported evidence that depression was associated with 
subsequent smoking behavior.44 The other four reported that smok-
ing status was associated with later depression.80,83,87,88 Other studies 
of clinical populations generally reported evidence of an association 
between smoking and the onset of depression.
Ethnic Differences
Five studies recruited participants of East Asian descent (China, 
Japan, and South Korea), with two studies reporting evidence that 
depression was associated with later smoking behavior 41,48 and 
one study reporting no evidence of an association.70 Additionally, 
two studies reported evidence for an association between smok-
ing status and later depression,70,99 while two studies reported 
no evidence that smoking status was associated with subsequent 
depression.48,108 Three studies recruited African American partici-
pants, with two studies reporting evidence that depression was 
associated with later smoking behavior,54,64 one study report-
ing no evidence that depression was associated with subsequent 
smoking onset,153 and one study reporting no evidence that smok-
ing was associated with the onset of depression.64 Four studies 
recruited both African American and Hispanic participants, with 
three studies reporting that depression and anxiety were associ-
ated with subsequent smoking trajectories,43,131,156 while one study 
reported that smoking heaviness was associated with the onset 
of anxiety.130 Other studies of specific ethnic groups generally 
reported evidence of an association between smoking and later 
depression and anxiety.
Additional Analyses
No clear pattern of results was apparent when studies with different 
lengths of follow up were considered separately (see Supplementary 
Table S3). Additionally, the findings did not vary substantially 
between studies using different tests (interview vs. self-diagnostic 
test) or scales (continuous vs. categorical) to diagnose depression or 
anxiety (see Supplementary Table S4).
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Discussion
In general, the findings across the studies in our systematic review 
were inconsistent. Nearly half of the studies reported that baseline 
depression or anxiety was associated with some type of later smok-
ing behavior, whether it be the onset of smoking itself, increased 
smoking heaviness, or the transition from daily smoking into 
dependence. These findings support a self-medication model, sug-
gesting that individuals smoke to alleviate psychiatric symptoms.5,6 
However, over a third of the studies found evidence for a relation-
ship in the opposite direction whereby smoking exposure at base-
line was associated with later depression or anxiety, supporting the 
alternative hypothesis that prolonged smoking increases suscepti-
bility to depression and anxiety.8,9 Of course, these two putative 
causal pathways are not mutually exclusive, but interestingly there 
were relatively few studies reporting evidence for a bidirectional 
model relationship between smoking and depression and anxiety. 
One possible reason for this is that many studies only measured 
or analyzed the variables in the direction of their a priori hypoth-
esis. For example, studies examining factors for depression in later 
life measured smoking as a possible factor but typically did not 
analyze the association of baseline depression with later smok-
ing. Moreover, few studies reported null results; often these were 
only included alongside positive results relating to another out-
come. Additionally, it is possible the associations observed between 
smoking and mental health are a result of shared genetic and envi-
ronmental factors.6
There are a number of limitations that should be considered when 
interpreting these results. First, the studies included in this review 
varied substantially in population sampled, with some recruiting 
from the general population and others selectively recruiting by sex, 
ethnicity, clinical population, or some other characteristic (eg, at-
risk adolescents). This introduced substantial heterogeneity into the 
review, thus making meta-analysis inappropriate. The substantial 
heterogeneity between study populations could be responsible for 
the inconsistent results observed, and future reviews should consider 
analyzing different populations individually. Second, there was also 
substantial variation in study designs, including the length of follow 
up (between 2 months and 36 years) and confounders adjusted for. 
Measurement of depression or anxiety was based on a wide range 
of different diagnostic tests, with different cutoffs for determining 
clinical status. Sample size also varied substantially between studies, 
ranging from 59 to 90 627, suggesting that some smaller studies may 
be inadequately powered. This may lead to an increased likelihood 
of false positives since, among statistically significant findings, power 
declines the ratio of true positives to false positives decreases.159 This 
is because while 5% of null associations will be falsely declared as 
significant (assuming a 5% alpha level), the number of true positives 
correctly identified will decline as power declines (eg, from 80% of 
true associations correctly declared as significant in high powered 
studies to, say, only 20% in low powered studies).159 However, it 
is also worth noting that very large samples may detect statistically 
significant associations that are unlikely to be of clinical or popula-
tion health importance.
Third, we only included published studies, and while the inclu-
sion of unpublished studies may increase the likelihood of including 
lower quality work that has not been peer reviewed, it may also 
decrease publication bias, in which studies are only published if 
they have positive results. By expanding our search to include non-
published studies, it is possible we may have found more instances 
of null results. Fourth, we did not investigate whether quality of the 
individual studies was related to the nature of the results reported. 
However, this would be challenging, given the diversity of study 
designs among the included studies. Fifth, while we were able to 
categorize and investigate a range of different smoking behaviors, 
the same level of detail was not available for depression and anxi-
ety. Future reviews should investigate individual symptomology (eg, 
negative affect, somatic features, etc.) and their relationship with 
smoking behavior, as previous research has indicated that specific 
symptoms may be differentially associated with smoking motiva-
tions and tobacco withdrawal.160–162 However, this analysis was 
not possible with the data reviewed here. Sixth, we only focused on 
depression, anxiety, or comorbid depression and anxiety. However, 
several studies identified during screening included depression or 
anxiety subtypes (eg, post-traumatic stress disorder or social anxi-
ety). These were excluded in order to maximize comparability among 
included studies. Future studies should explore whether there is a 
more consistent pattern of relationship between smoking behavior 
and other diagnostic categories. However, given the disparate results, 
we observed in our more focused review, it is perhaps unlikely that 
clear relationships will emerge.
Despite the advantages of longitudinal studies, they cannot by 
themselves provide strong evidence of causality. However, applying 
latent variable mixture modeling to establish group-based trajecto-
ries, as some studies identified did, may help to identify different 
patterns within the data that may have otherwise gone unnoticed. 
Rather than clustering individuals into simply “smokers” and “non-
smokers,” mixture modeling can identify various groups such as 
“experimenters,” “early onset,” “late onset,” “stable,” or “late esca-
lating” smokers.163 This approach could provide insight into the type 
or critical age of smokers vulnerable to mental illness, or vice versa. 
It’s likely that our review did not yield more of these studies, as we 
did not include “trajectory” in our search terms. Future reviews 
should include an exhaustive search, including a variety of terms 
such as mixture modeling, latent class analysis, and latent trajectory 
analysis in addition to the term trajectory.
Additionally, future studies should therefore employ methods 
that enable stronger causal inference, such as Mendelian randomi-
zation (MR).164 This approach uses genetic polymorphisms that 
have been previously shown to be robustly associated with one of 
the exposures of interest; for example, the CHRNA5-A3-B4 gene 
cluster is associated with smoking quantity and tobacco depend-
ence165,166 and has been used in a number of MR studies.160 It is 
based on the principle that an individual inherits a random assort-
ment of genes from their parents, and these genes should not be 
associated with potential confounders.10 Therefore, in theory, a 
robust genetic influence to a particular exposure (eg, smoking) 
would be comparable to a randomized trial in which individuals 
are assigned to a high- or low-exposure group.164 In addition, envi-
ronmental factors cannot affect the genes that an individual is born 
with, so analyses are not subject to reverse causality or residual 
confounding. Two studies that have used MR have found no evi-
dence to support a causal association between smoking and depres-
sion and anxiety,117,167 while another found evidence to suggest 
that smoking was associated with lower odds of depression during 
pregnancy.168 The results of these studies suggest that observational 
findings of an association of smoking status with later psychological 
distress may be a result of shared vulnerability, residual confound-
ing, or reverse causality (eg, psychological distress associated with 
later smoking behavior).167 However, this review yielded the most 
findings in the direction of psychological distress associated with 
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later smoking behavior. This review found slightly more evidence 
to support a direction of psychological distress predicting later 
smoking behavior, which is not inconsistent with these MR stud-
ies.167,168 However, while both depression and anxiety are highly 
heritable,169,170 genomewide association studies have not identi-
fied genetic variants robustly and strongly associated with these 
outcomes.171 Therefore, it is not currently possible to use MR to 
examine whether depression and anxiety are associated with smok-
ing behavior, although this is likely to change in the near future as 
larger genomewide association studies of depression and anxiety 
emerge. Until such genomewide association studies emerge, it is not 
possible to directly test the causal hypothesis in this direction.
In summary, we found overall inconsistent findings regarding 
whether smoking leads to depression and anxiety, depression and 
anxiety results in smoking or increased smoking behavior, or there 
is a bidirectional relationship between the two. This conflicting evi-
dence suggests the need for future studies to focus on different meth-
odologies, such as MR, which will allow us to draw stronger causal 
inferences.
Supplementary Material
Supplementary Tables S1 to S4 can be found online at http://www.
ntr.oxfordjournals.org
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